1-20 of 52
Authors: Yannick Allanore
Journal Article
Comment on: Association of serum interferon alpha-2a levels with disease severity and prognosis in systemic sclerosis: reply Get access
Rheumatology, keaf100, https://doi.org/10.1093/rheumatology/keaf100
Published: 26 March 2025
Journal Article
A phase 2 randomized trial of safety and pharmacokinetics of IgPro20 and IgPro10 in patients with diffuse cutaneous systemic sclerosis
Rheumatology, keaf066, https://doi.org/10.1093/rheumatology/keaf066
Published: 05 February 2025
Journal Article
Association of serum interferon alpha-2a levels with disease severity and prognosis in systemic sclerosis Get access
Rheumatology, Volume 64, Issue 5, May 2025, Pages 2792–2801, https://doi.org/10.1093/rheumatology/keae546
Published: 10 October 2024
Journal Article
E061 Attitudes and barriers to pulmonary arterial hypertension screening in systemic sclerosis patients: a survey of UK-based rheumatologists
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.288, https://doi.org/10.1093/rheumatology/keae163.288
Published: 24 April 2024
Journal Article
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis
Rheumatology, Volume 63, Issue 11, November 2024, Pages 3124–3134, https://doi.org/10.1093/rheumatology/keae150
Published: 09 March 2024
Journal Article
Heart and systemic sclerosis—findings from a national cohort study
Rheumatology, Volume 63, Issue 12, December 2024, Pages 3380–3389, https://doi.org/10.1093/rheumatology/kead599
Published: 07 November 2023
Journal Article
Should complete B cell depletion be maintained in patients treated long-term with rituximab for rheumatoid arthritis?
Rheumatology, Volume 63, Issue 8, August 2024, Pages 2135–2141, https://doi.org/10.1093/rheumatology/kead528
Published: 04 October 2023
Journal Article
Prophylaxis with tixagevimab/cilgavimab is associated with lower COVID-19 incidence and severity in patients with autoimmune diseases
Rheumatology, Volume 63, Issue 6, June 2024, Pages 1632–1638, https://doi.org/10.1093/rheumatology/kead449
Published: 26 August 2023
Journal Article
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review
Rheumatology, Volume 62, Issue 12, December 2023, Pages 3785–3800, https://doi.org/10.1093/rheumatology/kead289
Published: 19 June 2023
Journal Article
Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease
Rheumatology, Volume 63, Issue 3, March 2024, Pages 639–647, https://doi.org/10.1093/rheumatology/kead280
Published: 09 June 2023
Journal Article
Characteristics of patients with difficult-to-treat rheumatoid arthritis in a French single-centre hospital
Rheumatology, Volume 62, Issue 12, December 2023, Pages 3866–3874, https://doi.org/10.1093/rheumatology/kead143
Published: 24 March 2023
Journal Article
Sex influence on outcomes of patients with systemic sclerosis–associated interstitial lung disease: a EUSTAR database analysis
Rheumatology, Volume 62, Issue 7, July 2023, Pages 2483–2491, https://doi.org/10.1093/rheumatology/keac660
Published: 22 November 2022
Journal Article
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2178–2188, https://doi.org/10.1093/rheumatology/keac576
Published: 12 October 2022
Journal Article
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1877–1886, https://doi.org/10.1093/rheumatology/keac557
Published: 29 September 2022
Journal Article
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model
Rheumatology, Volume 62, Issue SI, February 2023, Pages SI91–SI100, https://doi.org/10.1093/rheumatology/keac405
Published: 29 July 2022
Journal Article
Increased antibody response after SARS-CoV-2 mRNA-based vaccination in rituximab-treated patients with previous COVID-19 infection
Rheumatology, Volume 61, Issue SI2, June 2022, Pages SI191–SI193, https://doi.org/10.1093/rheumatology/keac201
Published: 31 March 2022
Journal Article
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort
Rheumatology, Volume 61, Issue 12, December 2022, Pages 4786–4796, https://doi.org/10.1093/rheumatology/keac188
Published: 28 March 2022
Journal Article
Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment
Rheumatology, Volume 61, Issue 10, October 2022, Pages 4035–4046, https://doi.org/10.1093/rheumatology/keac126
Published: 03 March 2022
Journal Article
Nailfold capillaroscopy in SSc: innocent bystander or promising biomarker for novel severe organ involvement/progression?
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4384–4396, https://doi.org/10.1093/rheumatology/keac079
Published: 17 February 2022
Journal Article
Dyspnoea and cough in patients with systemic sclerosis–associated interstitial lung disease in the SENSCIS trial
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4397–4408, https://doi.org/10.1093/rheumatology/keac091
Published: 12 February 2022
